Treating a dog with autoimmune disease typically starts with suppressing the overactive immune system using steroids, then gradually tapering medication over months while monitoring for relapse. The specific approach depends on which condition your dog has, how severe it is, and how well they tolerate the initial drugs. Most dogs respond to first-line treatment, but managing the disease is a long process that requires patience, regular vet visits, and attention to side effects.
What Autoimmune Disease Looks Like in Dogs
Autoimmune diseases happen when a dog’s immune system mistakenly attacks its own healthy cells. The most common forms target specific tissues: red blood cells (immune-mediated hemolytic anemia, or IMHA), platelets that help with clotting (immune thrombocytopenia, or ITP), joints (immune-mediated polyarthritis, or IMPA), or skin (pemphigus). Each condition has different warning signs, but some overlap.
Dogs with IMHA often develop pale gums, dark-colored urine, sudden weakness, and rapid breathing because their body is destroying its own red blood cells faster than it can replace them. ITP causes bruising on the gums or belly, blood in the stool or urine, and tiny red dots on the skin from uncontrolled bleeding. IMPA shows up as fever, lethargy, loss of appetite, and shifting lameness, with multiple joints (especially the wrists and ankles) becoming painful, swollen, or stiff. Some dogs cycle between limping on different legs.
Getting a diagnosis usually involves bloodwork and sometimes more targeted testing. For joint disease, your vet will draw fluid from at least three affected joints to look for inflammation patterns that distinguish autoimmune arthritis from infection. For blood-related conditions, specific tests check whether the immune system is coating and destroying red blood cells or platelets.
First-Line Treatment: Steroids
Steroids are the cornerstone of treatment for nearly every canine autoimmune condition. Prednisolone is the most commonly prescribed, given orally once daily at an immunosuppressive dose. For dogs under about 33 pounds, the typical starting dose is weight-based. For larger dogs, the dose is calculated using body surface area, which prevents overdosing in bigger breeds. If your dog can’t keep oral medication down, an injectable steroid can be substituted until they’re eating normally.
You’ll usually see improvement within the first one to two weeks, though some conditions take longer to stabilize. The goal is to get the disease under control quickly, then begin slowly reducing the dose. Stopping steroids abruptly is dangerous, both because the disease can flare and because the body needs time to resume producing its own natural steroids.
Tapering is gradual. Your vet will reduce the dose in small increments, typically every two to four weeks, while checking bloodwork or symptoms at each step. If your dog relapses during a taper, the dose goes back up and the process starts again more slowly. Many dogs stay on some level of medication for six months to a year or longer.
When Steroids Aren’t Enough
Some dogs need a second immunosuppressive drug added to their treatment. This is especially true for severely ill dogs, those who depend on blood transfusions after the first week of treatment, or dogs that develop intolerable steroid side effects. Dogs with other health conditions like diabetes, heart disease, or kidney disease are also poor candidates for long-term high-dose steroids, so a second agent lets the vet lower the steroid dose sooner.
The most common add-on drugs include cyclosporine (which blocks a specific immune signaling pathway), mycophenolate (available in both oral and injectable forms, making it useful for hospitalized dogs), and azathioprine (an older option with less supporting evidence but still used for several autoimmune conditions including IMHA, ITP, and immune-mediated muscle disease). A fourth option, leflunomide, is sometimes chosen for cases that don’t respond to others. With any of these drugs, your vet will typically want to see at least six weeks of treatment at full dose before considering a taper.
These medications all carry their own side effects, most commonly digestive upset and suppression of bone marrow function, so regular blood monitoring is part of the deal.
Managing Steroid Side Effects at Home
The side effects of steroids are often the hardest part of treatment for both dogs and their owners. Increased thirst, frequent urination (sometimes including accidents in housetrained dogs), and a ravenous appetite are almost universal at higher doses. These aren’t signs that something is wrong with treatment; they’re expected consequences of the medication.
A few practical strategies help. If your dog is on a short-acting oral steroid, adjusting the timing of the dose (for example, giving it in the morning so the peak effects wear off overnight) can reduce nighttime accidents. Switching to a slightly modified form of prednisolone called methylprednisolone causes less salt retention, which means less thirst and fewer urination issues. Make sure fresh water is always available, and plan for extra bathroom breaks, especially in the first few weeks when doses are highest.
For the increased appetite, stick to your dog’s normal meal portions and use low-calorie treats if needed. Weight gain on steroids is common and adds stress to joints and organs, so staying ahead of it matters. Panting, restlessness, and a pot-bellied appearance can also develop with longer-term use. These typically improve as the dose tapers down.
Nutritional Support During Treatment
Omega-3 fatty acids have genuine anti-inflammatory effects and can complement medical treatment. In one study of 93 dogs with allergic and inflammatory conditions, a diet high in omega-3s produced good to excellent results in at least a third of the animals. While that study focused on allergies, the underlying anti-inflammatory mechanism is relevant to autoimmune disease more broadly.
Fish oil supplements are the most common source of omega-3s for dogs. When supplementing with higher amounts of omega-3 oils, adding vitamin E or another antioxidant to the diet is recommended, because omega-3 fatty acids increase the body’s need for antioxidant protection. Your vet can suggest an appropriate dose based on your dog’s size and condition. Beyond omega-3s, feeding a high-quality, easily digestible diet helps support a dog whose body is already under significant stress from both the disease and the medications used to treat it.
Relapse Rates and What to Watch For
Autoimmune diseases in dogs are manageable, but relapse is a real possibility. A study published in the Journal of Veterinary Internal Medicine tracked dogs with the three most common immune-mediated conditions and found distinct relapse patterns. Dogs with IMHA had an 11% relapse rate at one year and 18% at two years, with relapses occurring a median of six months after initial treatment. ITP followed a similar trajectory: 11% at one year, rising to 23% at two years, with a median relapse time of 10 months.
IMPA carries the highest relapse risk. About 35% of dogs relapsed within the first year, and 41% within two years. The median time to relapse was seven months. These numbers underscore why tapering is done so cautiously and why vets want to see prolonged stability before discontinuing medication entirely.
After your dog finishes treatment, watch for the original symptoms returning. With IMHA, that means pale gums, lethargy, or dark urine. With ITP, look for new bruising or bleeding. With IMPA, renewed stiffness, limping, or fever. Catching a relapse early generally means it can be controlled again with a shorter, less aggressive course of treatment than the first round.
The Long View on Treatment
Treating a dog with autoimmune disease is not a quick fix. From the initial high-dose phase through the slow taper and monitoring period, you’re looking at a minimum of several months and often a year or more of active management. Some dogs eventually come off all medication and stay in remission. Others need a low maintenance dose indefinitely.
The financial and time commitment is significant. Expect frequent vet visits for bloodwork during the first few months, potentially every two to four weeks, with visits spacing out as your dog stabilizes. The medications themselves range from relatively inexpensive (generic steroids) to more costly (cyclosporine, mycophenolate). Pet insurance may cover some of the cost if the policy was in place before diagnosis.
Dogs that respond to initial treatment generally have a good quality of life. The disease itself is serious, particularly IMHA, which can be life-threatening in its acute phase. But once stabilized, most dogs return to normal activity levels and behavior. The key is consistent medication, regular monitoring, and not rushing the taper because your dog looks and feels better.